Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.7400 AUD | -0.67% |
|
+0.68% | -41.73% |
03/07 | Monash IVF Group Discloses Interim Remuneration Package for Acting CEO | MT |
13/06 | Monash IVF Says Challenger Ceases to Be a Substantial Holder | MT |
Projected Income Statement: Monash IVF Group Limited
Annual
Quarterly
Halfyear
Annual
Quarterly
Halfyear
Fiscal Period: June | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
---|---|---|---|---|---|---|---|---|
Net sales 1 | 145.4 | 183.6 | 192.3 | 213.6 | 255 | 268.7 | 271.4 | 281.5 |
Change | - | 26.26% | 4.73% | 11.07% | 19.37% | 5.38% | 1% | 3.73% |
EBITDA 1 | 34.8 | 47.75 | 48.14 | 53.43 | 62.81 | 65.93 | 65.62 | 68.58 |
Change | - | 37.22% | 0.83% | 10.98% | 17.55% | 4.98% | -0.48% | 4.51% |
EBIT 1 | 24.45 | 34.86 | 33.36 | 38.09 | 44.23 | 45.32 | 43.19 | 45.7 |
Change | - | 42.58% | -4.31% | 14.18% | 16.12% | 2.46% | -4.7% | 5.83% |
Interest Paid 1 | -5.7 | -2.451 | -2.147 | -3.279 | -5.312 | -6.66 | -7.46 | -7.02 |
Earnings before Tax (EBT) 1 | 16.13 | - | 26.22 | 29.84 | - | 42.3 | 35.32 | 37.88 |
Change | - | - | - | 13.79% | - | - | -16.49% | 7.22% |
Net income 1 | 11.73 | 25.15 | 18.41 | 21.84 | -5.949 | 29.03 | 24.98 | 26.6 |
Change | - | 114.46% | -26.81% | 18.65% | -127.24% | 587.95% | -13.94% | 6.46% |
Announcement Date | 23/8/20 | 23/8/21 | 25/8/22 | 21/8/23 | 21/8/24 | - | - | - |
1AUD in Million
Estimates
Forecast Balance Sheet: Monash IVF Group Limited
Fiscal Period: June | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
---|---|---|---|---|---|---|---|---|
Net Debt 1 | 4.2 | -7.1 | 2.1 | 31 | 48.7 | 92.2 | 82.1 | 74.8 |
Change | - | -269.05% | 129.58% | 1,376.19% | 57.1% | 89.45% | -10.95% | -8.89% |
Announcement Date | 23/8/20 | 23/8/21 | 25/8/22 | 21/8/23 | 21/8/24 | - | - | - |
1AUD in Million
Estimates
Cash Flow Forecast: Monash IVF Group Limited
Fiscal Period: June | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
---|---|---|---|---|---|---|---|---|
CAPEX 1 | 7.5 | 11.29 | 11.76 | 27.79 | 21.67 | 17.01 | 15.66 | 16.74 |
Change | - | 50.49% | 4.22% | 136.24% | -22.01% | -21.5% | -7.96% | 6.93% |
Free Cash Flow (FCF) 1 | 23.6 | - | 16.7 | - | 30.85 | 6 | 32.5 | 35.5 |
Change | - | - | - | - | - | -80.55% | 441.67% | 9.23% |
Announcement Date | 23/8/20 | 23/8/21 | 25/8/22 | 21/8/23 | 21/8/24 | - | - | - |
1AUD in Million
Estimates
Forecast Financial Ratios: Monash IVF Group Limited
Fiscal Period: June | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
---|---|---|---|---|---|---|---|---|
Profitability | ||||||||
EBITDA Margin (%) | 23.93% | 26.01% | 25.04% | 25.02% | 24.63% | 24.54% | 24.18% | 24.36% |
EBIT Margin (%) | 16.81% | 18.99% | 17.35% | 17.83% | 17.35% | 16.87% | 15.91% | 16.24% |
EBT Margin (%) | 11.09% | - | 13.64% | 13.97% | - | 15.74% | 13.02% | 13.46% |
Net margin (%) | 8.06% | 13.7% | 9.57% | 10.22% | -2.33% | 10.8% | 9.21% | 9.45% |
FCF margin (%) | 16.23% | - | 8.68% | - | 12.1% | 2.23% | 11.98% | 12.61% |
FCF / Net Income (%) | 201.26% | - | 90.73% | - | -518.52% | 20.67% | 130.1% | 133.48% |
Profitability | ||||||||
ROA | 4.1% | 7.18% | 5.03% | 5.44% | 6.42% | 6.88% | 6.34% | 6.55% |
ROE | 5.7% | 8.6% | 8.2% | 9.3% | 10.7% | 11.58% | 10.41% | 10.88% |
Financial Health | ||||||||
Leverage (Debt/EBITDA) | 0.12x | - | 0.04x | 0.58x | 0.77x | 1.4x | 1.25x | 1.09x |
Debt / Free cash flow | 0.18x | - | 0.13x | - | 1.58x | 15.37x | 2.53x | 2.11x |
Capital Intensity | ||||||||
CAPEX / Current Assets (%) | 5.16% | 6.15% | 6.12% | 13.01% | 8.5% | 6.33% | 5.77% | 5.95% |
CAPEX / EBITDA (%) | 21.55% | 23.64% | 24.43% | 52.01% | 34.51% | 25.8% | 23.86% | 24.41% |
CAPEX / FCF (%) | 31.78% | - | 70.44% | - | 70.26% | 283.55% | 48.18% | 47.16% |
Items per share | ||||||||
Cash flow per share 1 | 0.1204 | 0.1127 | 0.0814 | 0.0997 | 0.1348 | 0.0873 | 0.1304 | 0.1282 |
Change | - | -6.4% | -27.77% | 22.48% | 35.2% | -35.22% | 49.31% | -1.67% |
Dividend per Share 1 | 0.021 | 0.042 | 0.044 | 0.044 | 0.05 | 0.0489 | 0.0458 | 0.0489 |
Change | - | 100% | 4.76% | 0% | 13.64% | -2.18% | -6.34% | 6.77% |
Book Value Per Share 1 | 0.9768 | 0.6844 | 0.6876 | 0.7012 | 0.6208 | 0.6344 | 0.6527 | 0.6726 |
Change | - | -29.93% | 0.46% | 1.98% | -11.46% | 2.18% | 2.88% | 3.06% |
EPS 1 | 0.045 | - | 0.047 | 0.056 | -0.017 | 0.0722 | 0.0633 | 0.069 |
Change | - | - | - | 19.15% | -130.36% | 525% | -12.36% | 8.99% |
Nbr of stocks (in thousands) | 389,635 | 389,635 | 389,635 | 389,635 | 389,635 | 389,635 | 389,635 | 389,635 |
Announcement Date | 23/8/20 | 23/8/21 | 25/8/22 | 21/8/23 | 21/8/24 | - | - | - |
1AUD
Estimates
2025 * | 2026 * | |
---|---|---|
P/E ratio | 10.3x | 11.8x |
PBR | 1.17x | 1.14x |
EV / Sales | 1.42x | 1.37x |
Yield | 6.57% | 6.15% |
More valuation ratios
* Estimated data
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Sell
Buy

Mean consensus
BUY
Number of Analysts
7
Last Close Price
0.7450AUD
Average target price
1.100AUD
Spread / Average Target
+47.63%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- MVF Stock
- Financials Monash IVF Group Limited
Select your edition
All financial news and data tailored to specific country editions

MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition